CEPH Message Board - Msg: 997904

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: KurtVedder who wrote (67)	3/15/1997 8:10:00 PM
From: harkenman	of 998

Fact #4: Besides Myotrophin/Provigil all other CEPH products are at least 3 to 7 years away. The aforementioned two have close to no prospects for comercial success. Everything else is too far away. This infomation was taken from: FORM 10-K405 Filed March 13, 1997 sec.gov The following table outlines Cephalon product development programs. ---------------------------------------------------------------------- Indication Compound Status ---------------------------------------------------------------------- ALS......................MYOTROPHIN (rhIGF-I) NDA Peripheral Neuropathies..MYOTROPHIN (rhIGF-I) Phase II Narcolepsy...............PROVIGIL (modafinil) NDA(4) Alzheimer's Disease......Signal Transduction Modulators Development Regulators of Gene Transcription Development .AP Inhibitors Research Stroke...................Calpain Inhibitors Research Prostate Disease.........Signal Transduction Modulators Phase I Cephalon has never obatined approval yet for a drug candidates. Myotrophin and Provigil are almost long shots commercially. Face the facts! Sell now for a small profit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next